Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Complement inhibition attenuates human lung transplant reperfusion injury: a multicenter trial.

Literature DB >> 10424589

Complement inhibition attenuates human lung transplant reperfusion injury: a multicenter trial.

M R Zamora¹, R D Davis, S H Keshavjee, L Schulman, J Levin, U Ryan, G A Patterson.

Abstract

Entities: Species

Mesh：

Substances：

Year: 1999 PMID： 10424589 DOI： 10.1378/chest.116.suppl_1.46s

Source DB: PubMed Journal: Chest ISSN： 0012-3692 Impact factor: 9.410

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

Review 1. The complement cascade as a therapeutic target in intracerebral hemorrhage.

Authors: Andrew F Ducruet; Brad E Zacharia; Zachary L Hickman; Bartosz T Grobelny; Mason L Yeh; Sergey A Sosunov; E Sander Connolly
Journal: Exp Neurol Date: 2009-07-24 Impact factor: 5.330

Review 2. Complement inhibition as a proposed neuroprotective strategy following cardiac arrest.

Authors: Brad E Zacharia; Zachary L Hickman; Bartosz T Grobelny; Peter A DeRosa; Andrew F Ducruet; E Sander Connolly
Journal: Mediators Inflamm Date: 2010-01-26 Impact factor: 4.711

Review 3. Development of complement therapeutics for inhibition of immune-mediated red cell destruction.

Authors: Karina Yazdanbakhsh
Journal: Transfusion Date: 2005-08 Impact factor: 3.157

4. Identification of a complement receptor 1 peptide for inhibition of immune hemolysis.

Authors: Jin Yu; Susanne Heck; Asim Debnath; Karina Yazdanbakhsh
Journal: Biochem Biophys Res Commun Date: 2006-12-11 Impact factor: 3.575

Review 5. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part III: Mechanisms: A 2016 Consensus Group Statement of the International Society for Heart and Lung Transplantation.

Authors: Andrew E Gelman; Andrew J Fisher; Howard J Huang; Maher A Baz; Ciara M Shaver; Thomas M Egan; Micheal S Mulligan
Journal: J Heart Lung Transplant Date: 2017-07-24 Impact factor: 10.247

6. Donor pretreatment with nebulized complement C3a receptor antagonist mitigates brain-death induced immunological injury post-lung transplant.

Authors: Qi Cheng; Kunal Patel; Biao Lei; Lindsay Rucker; D Patterson Allen; Peng Zhu; Chentha Vasu; Paulo N Martins; Martin Goddard; Satish N Nadig; Carl Atkinson
Journal: Am J Transplant Date: 2018-04-10 Impact factor: 8.086

Complement inhibition attenuates human lung transplant reperfusion injury: a multicenter trial.

Review 1. The complement cascade as a therapeutic target in intracerebral hemorrhage.

Review 2. Complement inhibition as a proposed neuroprotective strategy following cardiac arrest.

Review 3. Development of complement therapeutics for inhibition of immune-mediated red cell destruction.

4. Identification of a complement receptor 1 peptide for inhibition of immune hemolysis.

Review 5. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part III: Mechanisms: A 2016 Consensus Group Statement of the International Society for Heart and Lung Transplantation.

6. Donor pretreatment with nebulized complement C3a receptor antagonist mitigates brain-death induced immunological injury post-lung transplant.

Review 7. Inflammatory response to pulmonary ischemia-reperfusion injury.

Review 8. Anti-inflammatory strategies to enhance islet engraftment and survival.

9. Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation.

Review 10. Primary graft dysfunction: lessons learned about the first 72 h after lung transplantation.